Finance

Beta
Lists
214450:KOSDAQ
PharmaResearch Co Ltd
â‚©259,000.00
-9.60%
(-27,500.00) 1D
Jun 8, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214450...
Open
â‚©258,000
High
â‚©269,500
Low
â‚©255,000
Mkt. cap
2.69T
Avg. vol.
110.86K
Volume
114.54K
Dividend
1.43%
Quarterly dividend
â‚©925
Ex-dividend date
Dec 27, 2024
P/E ratio
16.54
52-wk high
â‚©713,000
52-wk low
â‚©255,000
EPS
â‚©15,656
Shares outstanding
10.39M
No. of employees
497
Open
â‚©258,000
High
â‚©269,500
Low
â‚©255,000
Mkt. cap
2.69T
Avg. vol.
110.86K
Volume
114.54K
Dividend
1.43%
Quarterly dividend
â‚©925
Ex-dividend date
Dec 27, 2024
P/E ratio
16.54
52-wk high
â‚©713,000
52-wk low
â‚©255,000
EPS
â‚©15,656
Shares outstanding
10.39M
No. of employees
497
News stories
From sources across the web
About PharmaResearch Co Ltd
CEOJung Sangsoo
Employees497
Founded1993
Headquarters-
SectorBiotechnology
Websitepharmaresearch.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
140.61B
135.43B
143.35B
146.10B
Cost of goods sold
33.41B
26.28B
33.92B
33.17B
Cost of revenue
33.41B
26.28B
33.92B
33.17B
Research and development expenses
8.02B
8.23B
11.80B
10.10B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.89B
36.01B
42.78B
42.31B
Operating expense
51.32B
47.27B
59.58B
55.35B
Total operating expenses
84.73B
73.56B
93.50B
88.53B
Operating income
55.88B
61.87B
49.84B
57.57B
Other non operating income
-3.80B
2.97B
-615.72M
-491.30M
EBT including unusual items
55.83B
64.83B
49.91B
68.02B
EBT excluding unusual items
54.94B
64.84B
50.89B
62.26B
Income tax expense
13.78B
13.97B
10.58B
19.27B
Effective tax rate
24.69%
21.56%
21.20%
28.33%
Other operating expenses
60.18M
290.06M
105.71M
540.02M
Net income
47.40B
48.97B
32.57B
47.57B
Net profit margin
33.71%
36.16%
22.72%
32.56%
Earnings per share
-
-
3.05K
4.24K
Interest and investment income
3.13B
-
5.81B
5.00B
Interest expense
-2.38B
-
-2.75B
-2.56B
Net interest expenses
748.37M
-
3.06B
2.44B
Depreciation and amortization charges
1.42B
1.46B
1.50B
1.55B
EBITDA
59.82B
65.89B
53.92B
61.77B
Gain or loss from assets sale
5.22M
-11.44K
-8.83M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer